Navidea Biopharmaceuticals, Inc. (NYSEMKT:NAVB)

CAPS Rating: 2 out of 5

Recs

0
Player Avatar awallejr (82.46) Submitted: 9/23/2012 10:41:21 PM : Outperform Start Price: $3.02 NAVB Score: -31.20

porte

Report this Post 2 Replies
Member Avatar portefeuille (99.78) Submitted: 9/26/2012 3:21:23 PM
Recs: 0

see comment #9 here -> http://caps.fool.com/Blogs/763415.

Report this Post
Member Avatar awallejr (82.46) Submitted: 3/22/2013 9:31:13 PM
Recs: 0

Rats I had the chance to close this in the green and wasn't paying attention.

Report this Post

Featured Broker Partners


Advertisement